PF-06678419
PF-06678419 is a sodium-coupled citrate transporter and sodium-dependent dicarboxylate transporter inhibitor. PF-06678419 inhibits citrate uptake by interacting with residues near and outside NaCT’s citrate binding site. PF-06678419 can be used for the research of type 2 diabetes mellitus.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- CAS. Nr.: 2055468-48-7
- Formel: C12H13IO5
- Molecular Weight:364.14
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biologische Aktivität
-
Chemical Information
- Reinheit & Dokumentation
- Verweise
-
Help & FAQs
Biologische Aktivität
PF-06678419 (Compound 4) (30 min) potently inhibits NaCT-mediated citrate uptake in HEK_NaCT cells with an IC50 of 0.44 μM, but lacks selectivity, also inhibiting NaDC1 and NaDC3 with IC50 values of 5.5 μM and 3.2 μM, respectively[1].
PF-06678419 binds to the putative citrate binding site of a human NaCT homology model, with key interactions involving residues G228, V231, V232, and G409[2].
PF-06678419 (10 µM; 12 min) shows altered inhibitory activity against mutant human NaCT-expressing HEK-293 cells, with increased affinity for NaCTQ77K and NaCTV231A mutants, reduced activity against NaCTG228A, NaCTV232A, NaCTV232I, NaCTG409N, and NaCTR481I mutants, and reduced sensitivity (IC50 ≥25 µM) for NaCTG228A and NaCTG409N mutants[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS. Nr. 2055468-48-7
-
Molecular Weight 364.14
-
Formel C12H13IO5
-
SMILES
[C@@](CCC1=CC=C(I)C=C1)(CC(O)=O)(C(O)=O)O
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Reinheit & Dokumentation
Verweise
[1]. Huard K, et al. Discovery and characterization of novel inhibitors of the sodium-coupled citrate transporter (NaCT or SLC13A5). Sci Rep. 2015;5:17391. Published 2015 Dec 1. [Content Brief]
[2]. Pajor AM, et al. Molecular Basis for Inhibition of the Na+/Citrate Transporter NaCT (SLC13A5) by Dicarboxylate Inhibitors. Mol Pharmacol. 2016;90(6):755-765. [Content Brief]
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)
PF-06678419 Related Classifications
HY-124661 Related Classifications
Powered by Bioz